Actively Recruiting

Phase 2
Age: 18Years - 99Years
All Genders
NCT04770207

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Led by Second Affiliated Hospital of Guangzhou Medical University · Updated on 2024-08-21

100

Participants Needed

1

Research Sites

782 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.

CONDITIONS

Official Title

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Solid advanced malignant tumors
  • Age between 18 and 99 years
  • Life expectancy is greater than three months
Not Eligible

You will not qualify if you...

  • Benign tumor
  • Life expectancy is less than three months
  • Serious medical comorbidity
  • Others

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Second Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China, 510260

Actively Recruiting

Loading map...

Research Team

B

Bingjia He, MD

CONTACT

Z

Zhenfeng Zhang, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here